Neurodegeneration with Brain Iron Accumulation 4 disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

NBIA4 MCID: NRD014 MIFTS: 37	Neurodegeneration with Brain Iron Accumulation 4 (NBIA4) Categories: Eye diseases, Genetic diseases, Mental diseases, Metabolic diseases, Neuronal diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Expand all tables

Sources

Aliases & Classifications for Neurodegeneration with Brain Iron Accumulation 4

MalaCards integrated aliases for Neurodegeneration with Brain Iron Accumulation 4:

Name: Neurodegeneration with Brain Iron Accumulation 4 ⁵⁷ ¹² ⁷⁵ ²⁹ ¹³ ⁶ ¹⁵ ⁷³

Nbia4 ⁵⁷ ¹² ⁵⁹ ⁷⁵

Mpan ⁵⁷ ¹² ⁵⁹ ⁷⁵

Neurodegeneration with Brain Iron Accumulation Due to C19orf12 Mutation ¹² ⁵⁹

Neurodegeneration with Brain Iron Accumulation Type 4 ¹² ⁵⁹

Mitochondrial Protein-Associated Neurodegeneration ⁵⁷ ¹²

Nbia Due to C19orf12 Mutation ¹² ⁵⁹

Mitochondrial Membrane Protein-Associated Neurodegeneration ⁵⁹

Mitochondrial Membrane Protein Associated Neurodegeneration ⁷⁵

Mitochondrial Protein-Associated Neurodegeneration; Mpan ⁵⁷

Neurodegeneration, with Brain Iron Accumulation, Type 4 ⁴⁰

Characteristics:

Orphanet epidemiological data:

⁵⁹

mitochondrial membrane protein-associated neurodegeneration
Inheritance: Autosomal recessive; Prevalence: 1-9/1000000 (Worldwide); Age of onset: Adolescent,Adult,Childhood; Age of death: adult,young Adult;

OMIM:

⁵⁷

Inheritance:
autosomal recessive

Miscellaneous:
variable phenotype
progressive disorder
later onset has been reported
onset usually in first decade
some patients may become wheelchair-bound

HPO:

³²

neurodegeneration with brain iron accumulation 4:
Onset and clinical course phenotypic variability progressive
Inheritance autosomal recessive inheritance

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases Metabolic diseases
Anatomical: Neuronal diseases Eye diseases Mental diseases

See all MalaCards categories (disease lists)

ICD10: ³³ ³⁴

Diseases of the nervous system

Extrapyramidal and movement disorders

Other degenerative diseases of basal ganglia

Hallervorden-Spatz disease

Orphanet: ⁵⁹

Rare neurological diseases

Rare eye diseases

External Ids:

OMIM ⁵⁷ 614298

Disease Ontology ¹² DOID:0110738

ICD10 ³³ G23.0

Orphanet ⁵⁹ ORPHA289560

ICD10 via Orphanet ³⁴ G23.0

MedGen ⁴² C3280371

MeSH ⁴⁴ D001480 D019150 D019189

SNOMED-CT via HPO ⁶⁹ 258211005 76976005 18963009 more

UMLS ⁷³ C3280371

Sources

Summaries for Neurodegeneration with Brain Iron Accumulation 4

OMIM : ⁵⁷ Neurodegeneration with brain iron accumulation-4 (NBIA4) is an autosomal recessive neurodegenerative disorder characterized by progressive spastic paraplegia, parkinsonism unresponsive to L-DOPA treatment, and psychiatric or behavioral symptoms. Other neurologic features, including optic atrophy, eye movement abnormalities, dystonia, dysphagia, dysarthria, and motor axonal neuropathy, may occur. Brain MRI shows T2-weighted hypointensities in the globus pallidus and substantia nigra. Onset is usually in the first 2 decades, but later onset has been reported (summary by Dogu et al., 2013). There is phenotypic variation: some patients may not have extrapyramidal signs and may have muscle weakness and atrophy as well as cognitive impairment or developmental delay (Deschauer et al., 2012) For a general phenotypic description and a discussion of genetic heterogeneity of NBIA, see NBIA1 (234200). (614298)

MalaCards based summary : Neurodegeneration with Brain Iron Accumulation 4, also known as nbia4, is related to neurodegeneration with brain iron accumulation and mitochondrial membrane protein-associated neurodegeneration, and has symptoms including ataxia, tremor and abnormal pyramidal signs. An important gene associated with Neurodegeneration with Brain Iron Accumulation 4 is C19orf12 (Chromosome 19 Open Reading Frame 12). Affiliated tissues include brain, eye and globus pallidus, and related phenotypes are spasticity and dysarthria

Disease Ontology : ¹² A neurodegeneration with brain iron accumulation that has material basis in autosomal recessive inheritance of mutation in the C19orf12 gene on chromosome 19q12.

UniProtKB/Swiss-Prot : ⁷⁵ Neurodegeneration with brain iron accumulation 4: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. NBIA4 results in speech difficulty, extrapyramidal signs, oromandibular and generalized dystonia, and parkinsonism. Most patients have progressive involvement of the corticospinal tract, with spasticity, hyperreflexia, and extensor plantar responses.

Sources

Related Diseases for Neurodegeneration with Brain Iron Accumulation 4

Diseases in the Neurodegeneration with Brain Iron Accumulation family:

Neurodegeneration with Brain Iron Accumulation 1	Neurodegeneration with Brain Iron Accumulation 2a
Neurodegeneration with Brain Iron Accumulation 5	Neurodegeneration with Brain Iron Accumulation 3
Neurodegeneration with Brain Iron Accumulation 2b	Neurodegeneration with Brain Iron Accumulation 4
Neurodegeneration with Brain Iron Accumulation 6	Neurodegeneration with Brain Iron Accumulation 7
Neurodegeneration with Brain Iron Accumulation 8

Diseases related to Neurodegeneration with Brain Iron Accumulation 4 via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 18)

#	Related Disease	Score	Top Affiliating Genes
1	neurodegeneration with brain iron accumulation	29.4	C19orf12 PANK2 PLA2G6 WDR45
2	mitochondrial membrane protein-associated neurodegeneration	11.8
3	axonal neuropathy	10.1
4	neuropathy	10.1
5	tremor	9.9	C19orf12 DNAJC13
6	neurodegeneration with brain iron accumulation 2b	9.8	PANK2 PLA2G6
7	neurodegeneration with brain iron accumulation 2a	9.8	PANK2 PLA2G6
8	kufor-rakeb syndrome	9.8	PANK2 PLA2G6
9	neuroaxonal dystrophy	9.8	PANK2 PLA2G6
10	aceruloplasminemia	9.7	PANK2 PLA2G6
11	hereditary spastic paraplegia	9.7	C19orf12 PLA2G6
12	parkinson disease 15, autosomal recessive early-onset	9.7	C19orf12 PANK2 PLA2G6
13	neurodegeneration with brain iron accumulation 3	9.7	C19orf12 PANK2 PLA2G6
14	neurodegeneration with brain iron accumulation 1	9.7	C19orf12 PANK2 PLA2G6
15	neurodegeneration with brain iron accumulation 6	9.7	C19orf12 PANK2 PLA2G6
16	3-methylglutaconic aciduria, type iii	9.7	C19orf12 PANK2 PLA2G6
17	neurodegeneration with brain iron accumulation 5	9.5	C19orf12 PANK2 PLA2G6 WDR45
18	dystonia	9.5	C19orf12 PANK2 PLA2G6 WDR45

Graphical network of the top 20 diseases related to Neurodegeneration with Brain Iron Accumulation 4:

Sources

Symptoms & Phenotypes for Neurodegeneration with Brain Iron Accumulation 4

Symptoms via clinical synopsis from OMIM:

⁵⁷

Neurologic Behavioral Psychiatric Manifestations:
emotional lability
impulsivity
depression
executive dysfunction
compulsions

Head And Neck Eyes:
optic atrophy
visual loss, progressive

Chest Ribs Sternum Clavicles And Scapulae:
scapular winging

Muscle Soft Tissue:
distal muscle weakness
distal muscle atrophy

Neurologic Peripheral Nervous System:
axonal motor neuropathy (in about 50%)
reduced nerve amplitudes of peroneal nerve

Neurologic Central Nervous System:
ataxia
spasticity
dysarthria
tremor
hyperreflexia
more

Skeletal Feet:
pes cavus
claw toes

Head And Neck Face:
oromandibular dystonia

Skeletal Hands:
atrophy of the small muscles in the hand

Laboratory Abnormalities:
increased serum creatine kinase, mild

Clinical features from OMIM:

614298

Human phenotypes related to Neurodegeneration with Brain Iron Accumulation 4:

⁵⁹ ³² (show all 47)

#	Description	HPO Frequency	Orphanet Frequency	HPO Source Accession
1	spasticity ⁵⁹ ³²		Very frequent (99-80%)	HP:0001257
2	dysarthria ⁵⁹ ³²		Very frequent (99-80%)	HP:0001260
3	gait disturbance ⁵⁹ ³²		Frequent (79-30%)	HP:0001288
4	optic atrophy ⁵⁹ ³²		Frequent (79-30%)	HP:0000648
5	babinski sign ⁵⁹ ³²		Very frequent (99-80%)	HP:0003487
6	parkinsonism ⁵⁹ ³²		Frequent (79-30%)	HP:0001300
7	emotional lability ³²			HP:0000712
8	depressivity ³²			HP:0000716
9	ataxia ³²			HP:0001251
10	muscle weakness ⁵⁹		Very frequent (99-80%)
11	tremor ³²			HP:0001337
12	hyperreflexia ³²			HP:0001347
13	dysphagia ⁵⁹		Frequent (79-30%)
14	respiratory insufficiency ⁵⁹		Very rare (<4-1%)
15	bowel incontinence ⁵⁹		Frequent (79-30%)
16	behavioral abnormality ⁵⁹		Very frequent (99-80%)
17	global developmental delay ³²	occasional (7.5%)		HP:0001263
18	delayed speech and language development ³²			HP:0000750
19	elevated serum creatine phosphokinase ³²			HP:0003236
20	progressive visual loss ³²			HP:0000529
21	abnormality of saccadic eye movements ⁵⁹		Occasional (29-5%)
22	pes cavus ³²			HP:0001761
23	dystonia ⁵⁹		Frequent (79-30%)
24	scapular winging ³²			HP:0003691
25	rigidity ⁵⁹		Very frequent (99-80%)
26	neurodegeneration ³²			HP:0002180
27	dementia ³²			HP:0000726
28	mental deterioration ⁵⁹		Very frequent (99-80%)
29	hyporeflexia ³²			HP:0001265
30	oromandibular dystonia ³²			HP:0012048
31	cerebellar atrophy ³²	occasional (7.5%)		HP:0001272
32	bradykinesia ⁵⁹		Frequent (79-30%)
33	shuffling gait ⁵⁹		Occasional (29-5%)
34	urinary incontinence ⁵⁹		Frequent (79-30%)
35	frequent falls ⁵⁹		Frequent (79-30%)
36	impulsivity ³²			HP:0100710
37	distal muscle weakness ³²			HP:0002460
38	postural instability ⁵⁹		Very frequent (99-80%)
39	lewy bodies ³²			HP:0100315
40	distal amyotrophy ³²			HP:0003693
41	hyperactive deep tendon reflexes ⁵⁹		Frequent (79-30%)
42	spastic paraparesis ⁵⁹		Frequent (79-30%)
43	motor axonal neuropathy ⁵⁹		Frequent (79-30%)
44	abnormal lower motor neuron morphology ³²			HP:0002366
45	hand tremor ⁵⁹		Very frequent (99-80%)
46	abnormality of the globus pallidus ⁵⁹		Frequent (79-30%)
47	abnormality of the substantia nigra ⁵⁹		Frequent (79-30%)

UMLS symptoms related to Neurodegeneration with Brain Iron Accumulation 4:

ataxia, tremor, abnormal pyramidal signs, abnormality of extrapyramidal motor function, oromandibular dystonia, muscle spasticity

Sources

Drugs & Therapeutics for Neurodegeneration with Brain Iron Accumulation 4

Search Clinical Trials , NIH Clinical Center for Neurodegeneration with Brain Iron Accumulation 4

Sources

Genetic Tests for Neurodegeneration with Brain Iron Accumulation 4

Genetic tests related to Neurodegeneration with Brain Iron Accumulation 4:

#	Genetic test	Affiliating Genes
1	Neurodegeneration with Brain Iron Accumulation 4 ²⁹	C19orf12

Sources

Anatomical Context for Neurodegeneration with Brain Iron Accumulation 4

MalaCards organs/tissues related to Neurodegeneration with Brain Iron Accumulation 4:

⁴¹

Brain, Eye, Globus Pallidus

Sources

Publications for Neurodegeneration with Brain Iron Accumulation 4

Articles related to Neurodegeneration with Brain Iron Accumulation 4:

#	Title	Authors	Year
1	Novel case of neurodegeneration with brain iron accumulation 4 (NBIA4) caused by a pathogenic variant affecting splicing. ( 30392167 )	Sparber P...Skoblov M	2018

Sources

Genes for Neurodegeneration with Brain Iron Accumulation 4

Genes related to Neurodegeneration with Brain Iron Accumulation 4 (1 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	C19orf12	Chromosome 19 Open Reading Frame 12	Protein Coding	1711.52	Molecular basis known ⁵⁷ Pathogenic ⁶ Causative germline mutation ⁵⁹ Causative variation ⁷⁵ Genetic Tests ²⁹ DISEASES inferred ¹⁵ GeneCards inferred via : Disorders Gene name Summaries Variants (show sections)	21981780 23269600 24575447 (more) 22508347 22584950 23857908 26187298 23278385 20039086
2	WDR45	WD Repeat Domain 45	Protein Coding	23.61	DISEASES inferred ¹⁵ GeneCards inferred via : Gene name (show sections)
3	PANK2	Pantothenate Kinase 2	Protein Coding	16.92	DISEASES inferred ¹⁵
4	PLA2G6	Phospholipase A2 Group VI	Protein Coding	16.52	DISEASES inferred ¹⁵
5	DNAJC13	DnaJ Heat Shock Protein Family (Hsp40) Member C13	Protein Coding	16.11	DISEASES inferred ¹⁵

Sources

Variations for Neurodegeneration with Brain Iron Accumulation 4

UniProtKB/Swiss-Prot genetic disease variations for Neurodegeneration with Brain Iron Accumulation 4:

⁷⁵ (show all 14)

#	Symbol	AA change	Variation ID	SNP ID
1	C19orf12	p.Thr11Met	VAR_066617	rs397514477
2	C19orf12	p.Gly53Arg	VAR_066618	rs200133991
3	C19orf12	p.Gly65Glu	VAR_066619	rs752450983
4	C19orf12	p.Gly69Arg	VAR_066620	rs515726205
5	C19orf12	p.Ser39Phe	VAR_069756	rs120486509
6	C19orf12	p.Ala48Pro	VAR_069757
7	C19orf12	p.Pro60Leu	VAR_069758
8	C19orf12	p.Gly65Val	VAR_069759	rs752450983
9	C19orf12	p.Pro83Leu	VAR_069760	rs201987973
10	C19orf12	p.Arg98Ser	VAR_069761	rs138493099
11	C19orf12	p.Leu121Gln	VAR_069762
12	C19orf12	p.Ala63Pro	VAR_070668	rs376103979
13	C19orf12	p.Gly58Ser	VAR_076803
14	C19orf12	p.Gln96Pro	VAR_076804

ClinVar genetic disease variations for Neurodegeneration with Brain Iron Accumulation 4:

⁶ (show top 50) (show all 212)

#	Gene	Variation	Type	Significance	SNP ID	Assembly	Location
1	C19orf12	C19ORF12, 11-BP DEL, NT204	deletion	Pathogenic
2	C19orf12	NM_001031726.3(C19orf12): c.32C> T (p.Thr11Met)	single nucleotide variant	Pathogenic	rs397514477	GRCh37	Chromosome 19, 30199322: 30199322
3	C19orf12	NM_001031726.3(C19orf12): c.32C> T (p.Thr11Met)	single nucleotide variant	Pathogenic	rs397514477	GRCh38	Chromosome 19, 29708415: 29708415
4	C19orf12	NM_001031726.2: c.205G> A	single nucleotide variant	Pathogenic
5	C19orf12	NM_001031726.3(C19orf12): c.424A> G (p.Lys142Glu)	single nucleotide variant	Conflicting interpretations of pathogenicity	rs146170087	GRCh37	Chromosome 19, 30193654: 30193654
6	C19orf12	NM_001031726.3(C19orf12): c.424A> G (p.Lys142Glu)	single nucleotide variant	Conflicting interpretations of pathogenicity	rs146170087	GRCh38	Chromosome 19, 29702747: 29702747
7	C19orf12	NM_001256047.1(C19orf12): c.362T> A (p.Leu121Gln)	single nucleotide variant	Pathogenic	rs387907173	GRCh37	Chromosome 19, 30193683: 30193683
8	C19orf12	NM_001256047.1(C19orf12): c.362T> A (p.Leu121Gln)	single nucleotide variant	Pathogenic	rs387907173	GRCh38	Chromosome 19, 29702776: 29702776
9	C19orf12	NM_001031726.3(C19orf12): c.187G> C (p.Ala63Pro)	single nucleotide variant	Likely pathogenic	rs376103979	GRCh37	Chromosome 19, 30199167: 30199167
10	C19orf12	NM_001031726.3(C19orf12): c.187G> C (p.Ala63Pro)	single nucleotide variant	Likely pathogenic	rs376103979	GRCh38	Chromosome 19, 29708260: 29708260
11	C19orf12	NM_001256047.1(C19orf12): c.164_166delGGG (p.Gly55del)	deletion	Pathogenic	rs398122409	GRCh37	Chromosome 19, 30193879: 30193881
12	C19orf12	NM_001256047.1(C19orf12): c.164_166delGGG (p.Gly55del)	deletion	Pathogenic	rs398122409	GRCh38	Chromosome 19, 29702972: 29702974
13	C19orf12	NM_001031726.3(C19orf12): c.357C> T (p.Thr119=)	single nucleotide variant	Benign	rs10424582	GRCh37	Chromosome 19, 30193721: 30193721
14	C19orf12	NM_001031726.3(C19orf12): c.357C> T (p.Thr119=)	single nucleotide variant	Benign	rs10424582	GRCh38	Chromosome 19, 29702814: 29702814
15	C19orf12	NM_001031726.3(C19orf12): c.425A> C (p.Lys142Thr)	single nucleotide variant	Benign/Likely benign	rs79915936	GRCh37	Chromosome 19, 30193653: 30193653
16	C19orf12	NM_001031726.3(C19orf12): c.425A> C (p.Lys142Thr)	single nucleotide variant	Benign/Likely benign	rs79915936	GRCh38	Chromosome 19, 29702746: 29702746
17	C19orf12	NM_001256047.1(C19orf12): c.171_181delCGGGGGGCTGT (p.Gly58Argfs)	deletion	Pathogenic	rs515726204	GRCh38	Chromosome 19, 29702957: 29702967
18	C19orf12	NM_001256047.1(C19orf12): c.171_181delCGGGGGGCTGT (p.Gly58Argfs)	deletion	Pathogenic	rs515726204	GRCh37	Chromosome 19, 30193864: 30193874
19	C19orf12	NM_001031726.3(C19orf12): c.205G> A (p.Gly69Arg)	single nucleotide variant	Pathogenic	rs515726205	GRCh37	Chromosome 19, 30193873: 30193873
20	C19orf12	NM_001031726.3(C19orf12): c.205G> A (p.Gly69Arg)	single nucleotide variant	Pathogenic	rs515726205	GRCh38	Chromosome 19, 29702966: 29702966
21	C19orf12	NM_001031726.3(C19orf12): c.157G> A (p.Gly53Arg)	single nucleotide variant	Pathogenic/Likely pathogenic	rs200133991	GRCh38	Chromosome 19, 29708290: 29708290
22	C19orf12	NM_001031726.3(C19orf12): c.157G> A (p.Gly53Arg)	single nucleotide variant	Pathogenic/Likely pathogenic	rs200133991	GRCh37	Chromosome 19, 30199197: 30199197
23	C19orf12	NM_001031726.3(C19orf12): c.258_259delGAinsTGGAGGAACAGT (p.Gln86Hisfs)	indel	Pathogenic	rs797045423	GRCh38	Chromosome 19, 29702912: 29702913
24	C19orf12	NM_001031726.3(C19orf12): c.258_259delGAinsTGGAGGAACAGT (p.Gln86Hisfs)	indel	Pathogenic	rs797045423	GRCh37	Chromosome 19, 30193819: 30193820
25	C19orf12	NM_001256047.1(C19orf12): c.215C> T (p.Pro72Leu)	single nucleotide variant	Pathogenic	rs201987973	GRCh38	Chromosome 19, 29702923: 29702923
26	C19orf12	NM_001256047.1(C19orf12): c.215C> T (p.Pro72Leu)	single nucleotide variant	Pathogenic	rs201987973	GRCh37	Chromosome 19, 30193830: 30193830
27	C19orf12	NM_001031726.3(C19orf12): c.249G> A (p.Pro83=)	single nucleotide variant	Conflicting interpretations of pathogenicity	rs202054484	GRCh38	Chromosome 19, 29702922: 29702922
28	C19orf12	NM_001031726.3(C19orf12): c.249G> A (p.Pro83=)	single nucleotide variant	Conflicting interpretations of pathogenicity	rs202054484	GRCh37	Chromosome 19, 30193829: 30193829
29	C19orf12	NM_001031726.3(C19orf12): c.102G> A (p.Ala34=)	single nucleotide variant	Conflicting interpretations of pathogenicity	rs201118405	GRCh37	Chromosome 19, 30199252: 30199252
30	C19orf12	NM_001031726.3(C19orf12): c.102G> A (p.Ala34=)	single nucleotide variant	Conflicting interpretations of pathogenicity	rs201118405	GRCh38	Chromosome 19, 29708345: 29708345
31	C19orf12	NM_001031726.3(C19orf12): c.*3520C> T	single nucleotide variant	Uncertain significance	rs886054311	GRCh37	Chromosome 19, 30190099: 30190099
32	C19orf12	NM_001031726.3(C19orf12): c.*3520C> T	single nucleotide variant	Uncertain significance	rs886054311	GRCh38	Chromosome 19, 29699192: 29699192
33	C19orf12	NM_001031726.3(C19orf12): c.*3372C> T	single nucleotide variant	Uncertain significance	rs117537955	GRCh37	Chromosome 19, 30190247: 30190247
34	C19orf12	NM_001031726.3(C19orf12): c.*3372C> T	single nucleotide variant	Uncertain significance	rs117537955	GRCh38	Chromosome 19, 29699340: 29699340
35	C19orf12	NM_001031726.3(C19orf12): c.*3337G> A	single nucleotide variant	Uncertain significance	rs868247639	GRCh37	Chromosome 19, 30190282: 30190282
36	C19orf12	NM_001031726.3(C19orf12): c.*3337G> A	single nucleotide variant	Uncertain significance	rs868247639	GRCh38	Chromosome 19, 29699375: 29699375
37	C19orf12	NM_001031726.3(C19orf12): c.*3336C> T	single nucleotide variant	Likely benign	rs10414583	GRCh37	Chromosome 19, 30190283: 30190283
38	C19orf12	NM_001031726.3(C19orf12): c.*3336C> T	single nucleotide variant	Likely benign	rs10414583	GRCh38	Chromosome 19, 29699376: 29699376
39	C19orf12	NM_001031726.3(C19orf12): c.*3294C> G	single nucleotide variant	Uncertain significance	rs886054313	GRCh37	Chromosome 19, 30190325: 30190325
40	C19orf12	NM_001031726.3(C19orf12): c.*3294C> G	single nucleotide variant	Uncertain significance	rs886054313	GRCh38	Chromosome 19, 29699418: 29699418
41	C19orf12	NM_001031726.3(C19orf12): c.*2961T> C	single nucleotide variant	Benign	rs10417597	GRCh38	Chromosome 19, 29699751: 29699751
42	C19orf12	NM_001031726.3(C19orf12): c.*2961T> C	single nucleotide variant	Benign	rs10417597	GRCh37	Chromosome 19, 30190658: 30190658
43	C19orf12	NM_001031726.3(C19orf12): c.*2956G> T	single nucleotide variant	Likely benign	rs113943151	GRCh38	Chromosome 19, 29699756: 29699756
44	C19orf12	NM_001031726.3(C19orf12): c.*2956G> T	single nucleotide variant	Likely benign	rs113943151	GRCh37	Chromosome 19, 30190663: 30190663
45	C19orf12	NM_001031726.3(C19orf12): c.*2763A> G	single nucleotide variant	Likely benign	rs113735809	GRCh38	Chromosome 19, 29699949: 29699949
46	C19orf12	NM_001031726.3(C19orf12): c.*2763A> G	single nucleotide variant	Likely benign	rs113735809	GRCh37	Chromosome 19, 30190856: 30190856
47	C19orf12	NM_001031726.3(C19orf12): c.*2186C> T	single nucleotide variant	Likely benign	rs73548135	GRCh38	Chromosome 19, 29700526: 29700526
48	C19orf12	NM_001031726.3(C19orf12): c.*2186C> T	single nucleotide variant	Likely benign	rs73548135	GRCh37	Chromosome 19, 30191433: 30191433
49	C19orf12	NM_001031726.3(C19orf12): c.*1686T> C	single nucleotide variant	Benign	rs7255131	GRCh38	Chromosome 19, 29701026: 29701026
50	C19orf12	NM_001031726.3(C19orf12): c.*1686T> C	single nucleotide variant	Benign	rs7255131	GRCh37	Chromosome 19, 30191933: 30191933

Sources

Expression for Neurodegeneration with Brain Iron Accumulation 4

Search GEO for disease gene expression data for Neurodegeneration with Brain Iron Accumulation 4.

Sources

Pathways for Neurodegeneration with Brain Iron Accumulation 4

Sources

GO Terms for Neurodegeneration with Brain Iron Accumulation 4

Cellular components related to Neurodegeneration with Brain Iron Accumulation 4 according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	integral component of membrane	GO:0016021	9.35	C19orf12 DNAJC13 PANK2 PLA2G6 WDR45
2	cytosol	GO:0005829	9.02	C19orf12 DNAJC13 PANK2 PLA2G6 WDR45

Biological processes related to Neurodegeneration with Brain Iron Accumulation 4 according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	autophagy	GO:0006914	8.62	C19orf12 WDR45

Sources

Sources for Neurodegeneration with Brain Iron Accumulation 4

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia

Neurodegeneration with Brain Iron Accumulation 4 (NBIA4)

Aliases & Classifications for Neurodegeneration with Brain Iron Accumulation 4

MalaCards integrated aliases for Neurodegeneration with Brain Iron Accumulation 4:

Characteristics:

Orphanet epidemiological data:

OMIM:

HPO:

Classifications:

External Ids:

Summaries for Neurodegeneration with Brain Iron Accumulation 4

Related Diseases for Neurodegeneration with Brain Iron Accumulation 4

Diseases in the Neurodegeneration with Brain Iron Accumulation family:

Diseases related to Neurodegeneration with Brain Iron Accumulation 4 via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Neurodegeneration with Brain Iron Accumulation 4:

Symptoms & Phenotypes for Neurodegeneration with Brain Iron Accumulation 4

Symptoms via clinical synopsis from OMIM:

Clinical features from OMIM:

Human phenotypes related to Neurodegeneration with Brain Iron Accumulation 4:

UMLS symptoms related to Neurodegeneration with Brain Iron Accumulation 4:

Drugs & Therapeutics for Neurodegeneration with Brain Iron Accumulation 4

Genetic Tests for Neurodegeneration with Brain Iron Accumulation 4

Genetic tests related to Neurodegeneration with Brain Iron Accumulation 4:

Anatomical Context for Neurodegeneration with Brain Iron Accumulation 4

MalaCards organs/tissues related to Neurodegeneration with Brain Iron Accumulation 4:

Publications for Neurodegeneration with Brain Iron Accumulation 4

Articles related to Neurodegeneration with Brain Iron Accumulation 4:

Genes for Neurodegeneration with Brain Iron Accumulation 4

Genes related to Neurodegeneration with Brain Iron Accumulation 4 (1 elite genes):

Variations for Neurodegeneration with Brain Iron Accumulation 4

UniProtKB/Swiss-Prot genetic disease variations for Neurodegeneration with Brain Iron Accumulation 4:

ClinVar genetic disease variations for Neurodegeneration with Brain Iron Accumulation 4:

Expression for Neurodegeneration with Brain Iron Accumulation 4

Pathways for Neurodegeneration with Brain Iron Accumulation 4

GO Terms for Neurodegeneration with Brain Iron Accumulation 4

Cellular components related to Neurodegeneration with Brain Iron Accumulation 4 according to GeneCards Suite gene sharing:

Biological processes related to Neurodegeneration with Brain Iron Accumulation 4 according to GeneCards Suite gene sharing:

Sources for Neurodegeneration with Brain Iron Accumulation 4